Sen. Ron Wyden, the lead Democrat on the Senate Finance Committee, wants Pfizer to explain its price increase on Lyrica, a nerve pain drug, STAT reports.
Currently, a prescription of 90 Lyrica pills can cost patients some $650 before rebates and discounts. According to the report, the same prescription would have cost about $150 in 2005.
“The cost of Pfizer’s drug, Lyrica, has grown tremendously over the past several years,” Wyden wrote in a letter to the drugmaker. “In 2016 alone, over 850,000 Medicare beneficiaries were prescribed Lyrica resulting in $2.1 billion Medicare spending. The main cause of this increase has been Pfizer’s consistent and egregious price increases.”
Wyden also expressed concerns about the Food and Drug Administration’s recent decision to grant an extra six months of exclusivity to Pfizer after green lighting the drug for treatment of seizures in children. The drug would have be open to generic competition later this month if not for the decision, according to the report.
To read the full report on STAT, click here.